Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTIPHOSPHOLIPID ANTIBODY - ANVISA Registration 80867150147

Access comprehensive regulatory information for ANTIPHOSPHOLIPID ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80867150147 and manufactured by SHENZHEN YHLO BIOTECH CO., LTD. The registration is held by BIOMOLECULAR TECHNOLOGY COMÉRCIO, IMPORTAÇÃO, EXPORTAÇÃO E DISTRIBUIÇÃO DE MATERIAIS MÉDICOS E LABORATORIAIS LTDA - EPP with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, INOVA DIAGNOSTICS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80867150147
Registration Details
ANVISA Registration Number: 80867150147
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Família iFlash Anti-B2-Glycoprotein I
Risk Class II

Registration Details

80867150147

25351353349202397

07767477000146

Company Information

Dates and Status

Jul 03, 2023

VIGENTE

09/18/2025 19:00:01